Vimarsana
Biggest News Aggregation in the World

Memory Disorders Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Memory Disorders Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Memory Disorders Division Today - Breaking & Trending Today

'There's a temptation to lump octogenarians together': What you should know about work and aging-brain health - Vimarsana News

'There's a temptation to lump octogenarians together': What you should know about work and aging-brain health

Many of the most powerful people in politics are in their 70s and 80s. So what are the benefits and challenges of having a career well into old age?

Source: yahoo.com
Memory loss: Misplacing keys isn't necessarily a sign of dementia - Vimarsana News

Memory loss: Misplacing keys isn't necessarily a sign of dementia

Experts say misplacing keys or other everyday items isn't necessarily a sign of dementia or other serious memory loss issues. They note there are ways you can keep your memory sharp.

Alzheimer's: Few people in early stages are eligible for new drugs - Vimarsana News

Alzheimer's: Few people in early stages are eligible for new drugs

Researchers say most people with early Alzheimer's are not eligible to be treated with two newly approved monoclonal antibody drugs, lecanemab and aducanumab

PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer's Disease Patients - Vimarsana News

PathGroup and uMETHOD Health Partner to Personalize Care for Mild Cognitive Impairment (MCI) and Early-stage Alzheimer's Disease Patients

/PRNewswire/ -- uMETHOD Health, a health technology company specializing in precision medicine for complex diseases, announces a partnership with PathGroup,...

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data - Vimarsana News

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for...